PELUSO, ROSARIO
 Distribuzione geografica
Continente #
AS - Asia 5.565
NA - Nord America 4.855
EU - Europa 4.147
SA - Sud America 647
AF - Africa 135
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.366
Nazione #
US - Stati Uniti d'America 4.657
SG - Singapore 2.602
RU - Federazione Russa 1.723
VN - Vietnam 1.022
IT - Italia 1.008
CN - Cina 996
BR - Brasile 524
HK - Hong Kong 468
FR - Francia 252
UA - Ucraina 237
DE - Germania 221
FI - Finlandia 184
IE - Irlanda 134
NL - Olanda 134
CA - Canada 104
GB - Regno Unito 96
JP - Giappone 74
BD - Bangladesh 69
IN - India 67
MX - Messico 55
IQ - Iraq 48
AR - Argentina 46
CI - Costa d'Avorio 41
ZA - Sudafrica 41
SE - Svezia 39
PL - Polonia 27
TH - Thailandia 27
PH - Filippine 25
PK - Pakistan 23
ES - Italia 21
TR - Turchia 19
EC - Ecuador 18
TW - Taiwan 17
VE - Venezuela 17
KR - Corea 16
LT - Lituania 11
PY - Paraguay 11
AT - Austria 10
CO - Colombia 10
CZ - Repubblica Ceca 10
JM - Giamaica 10
SA - Arabia Saudita 10
ID - Indonesia 9
LB - Libano 9
TN - Tunisia 9
UY - Uruguay 9
CH - Svizzera 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
AZ - Azerbaigian 7
MA - Marocco 7
JO - Giordania 6
CR - Costa Rica 5
ET - Etiopia 5
GT - Guatemala 5
KE - Kenya 5
NP - Nepal 5
BG - Bulgaria 4
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
OM - Oman 4
PE - Perù 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RO - Romania 3
SN - Senegal 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
Totale 15.341
Città #
Singapore 1.208
San Jose 655
Ashburn 449
Hong Kong 448
Moscow 428
Chandler 383
Ho Chi Minh City 305
Beijing 259
Hanoi 210
Santa Clara 205
Millbury 164
The Dalles 162
Jacksonville 152
Princeton 138
Lauterbourg 136
Naples 131
Nanjing 120
Boston 108
Amsterdam 106
Los Angeles 98
Buffalo 77
Napoli 72
Rome 67
Munich 66
New York 64
Tokyo 63
Wilmington 56
São Paulo 53
Redondo Beach 52
Boardman 51
Dallas 51
Milan 51
Des Moines 48
Da Nang 47
Hefei 46
Ottawa 46
Haiphong 45
Nanchang 42
Houston 30
Hải Dương 30
Orem 29
Seattle 29
Turku 29
Mexico City 27
Chicago 26
Hebei 26
Jiaxing 26
Frankfurt am Main 25
Helsinki 24
Bari 23
Biên Hòa 23
Lawrence 23
Brooklyn 22
Norwalk 22
Atlanta 21
Tianjin 21
Warsaw 21
Denver 20
Shenyang 19
Phoenix 18
Toronto 18
Baghdad 16
Dhaka 16
Dublin 16
Campinas 15
Chennai 15
Falkenstein 15
Johannesburg 15
Changsha 14
Manchester 14
Montreal 14
Stockholm 14
Poplar 13
Redwood City 13
Rio de Janeiro 13
Washington 13
Council Bluffs 12
Guangzhou 12
London 12
Palermo 12
Falls Church 11
Florence 11
Can Tho 10
Hangzhou 10
Nuremberg 10
Padova 10
Bangkok 9
Bến Tre 9
Montevideo 9
Porto Alegre 9
Belo Horizonte 8
Brasília 8
Cava de' Tirreni 8
Fortaleza 8
Kunming 8
New Delhi 8
San Francisco 8
Venice 8
Woodbridge 8
Bologna 7
Totale 7.855
Nome #
Artrite Psoriasica 742
Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies 171
Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies 162
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 160
Nail and Distal Interphalangeal Joint in Psoriatic Arthritis. 154
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 148
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 145
Management of arthropathy in inflammatory bowel diseases 144
Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies 141
Artrite psoriasica resistente a più DMARDs. 139
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 139
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. 138
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 138
Nuovi farmaci nell'artrite psoriasica. Etanercept. 135
Ankylosing spondylitis and posture control: The role of visual input 133
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 133
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 132
The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis 131
Cardiovascular effects of Etanercept in patients with psoriatic arthritis: Evidence from the cardiovascular risk in rheumatic diseases database 127
Small molecule therapy for managing moderate to severe psoriatic arthritis 124
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 123
Dactylitis in enteropathic spondyloarthritis 122
Magnetic resonance imaging of nail unit in psoriatic arthritis 122
contributo di ricerca 121
Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies 121
Psoriasi, artrite psoriasica o malattia psoriasica. 120
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 120
Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole. 119
Clinical presentation of Psoriatic Arthritis. 118
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 118
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 118
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 118
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 117
Is the involvement of distal interphalangeal joint of psoriatic pateints related to nail psoriasis? 117
La gravidanza nelle malattie autoimmuni: il rischio per la madre, per il feto e per il neonato. 117
Hepatic steatosis, carotid plaques and achieving MDA in psoriaticarthritis patients starting TNF-alpha blockers treatment: a prospective study. 117
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 117
Extra-articular manifestations in psoriatic arthritis patients 117
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 117
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 116
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. 116
Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor-α Blockers for Psoriatic Arthritis 116
Consecutive occurrence of rhinoconjunctivitis, seronegative spondyloarthritis and pyoderma gangrenosum in a patient with ulcerative colitis. 115
Clinical and genetic aspects of psoriatic arthritis "sine psoriasis" 113
contributo di ricerca 112
Infliximab in the treatment of seronegative spondyloarthropathies 111
Epidemiologia ed aspetti socioeconomici dell’osteoporosi. 111
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 111
contributo di ricerca 110
contributo di ricerca 109
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 109
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies 108
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 108
contributo di ricerca 107
Clinical presentation of psoriatic arthritis. 106
Rapporto intestino e spondiloartriti: dubbi e certezze 105
Psoriasis is not a risk factor for arthritis in patients with Crohn’s disease Rheumatology, 41:115, 2002. 104
R.SCARPA, E.COSENTINI, F.MANGUSO, A.ORIENTE, R.PELUSO, F.AYALA, P.ORIENTE Psoriarit arthritis “sine psoriasis” clinical and genetical aspects Rheumatology 42: (P103)53 , 2003. 103
OBESITY AND PSORIATIC ARTHRITIS: FROM PATHOGENESIS TO CLINICAL OUTCOME AND MANAGEMENT 102
Enteropathic spondyloarthritis: from diagnosis to treatment. 102
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 102
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 102
New developments in magnetic resonance imaging of the nail unit. 101
Carotid intima-media thickness in psoriatic arthritis: Differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs 101
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. 100
Artrite Psoriasica 99
Discovertebral Erosions in Patients with Enteropathic Spondyloarthritis. 99
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers 99
L’appendicectomia ritarda l’esordio clinico della rettocolite ulcerosa ma favorisce la comparsa di manifestazioni extraintestinali. 98
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs 98
Spondiloartriti sieronegative e patologia allergica nei pazienti con rettocolite ulcerosa. 97
Association of MICA alleles with psoriatic arthritis and its clinical forms. A Multicenter Italian study. 97
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report. 97
Spondiloartrosi sieronegative e patologia allergica nei pazienti con rettocolite ulcerosa 96
Il fumo e l’appendicectomia sono fattori di rischio per lo sviluppo di manifestazioni extraintestinali nella rettocolite ulcerosa. AnnI t Med Int 18:9S, 2003. 94
Artrite psoriasica 94
Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis. 94
– Le Spondiloartriti: dalla diagnosi al trattamento 93
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. 93
Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis 90
Ankylosing spondylitis: clinical aspects and diagnosis 89
Artrite Psoriasica "sine Psoriasi" 89
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 87
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 87
The early treatment of psoriatic arthritis 86
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 86
Emerging drugs for psoriatic arthritis 85
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 85
[Seronegative spondyloarthropathies and allergic diseases in patients with ulcerative colitis]. 84
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 84
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 84
Leflunomide in psoriatic polyarthropathis 83
Artrite Psoriasica 83
Le manifestazioni extra-articolari in corso di spondiloartrite. 83
Le raccomandazioni terapeutiche per l’uso degli anti TNF-alfa nell’artrite psoriasica e le evidenze della pratica clinica quotidiana 82
Articular and other immune-mediated extra-intestinal manifestations in inflammatory bowel diseases 82
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 82
E’ possibile caratterizzare sul piano clinico ed immunogenetico l’artrite psoriasica sine psoriasi? 81
La artropatia psoriasica. 78
Early Psoriatic Arthritis 78
Totale 11.611
Categoria #
all - tutte 49.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 48 9
2021/2022877 11 8 10 6 6 17 13 34 132 78 185 377
2022/2023963 169 61 26 73 105 121 7 88 146 110 44 13
2023/2024916 24 104 115 63 56 92 35 81 20 42 159 125
2024/20254.001 227 268 23 60 88 193 427 253 326 396 1.356 384
2025/20267.174 892 454 704 623 1.291 364 746 455 1.019 467 159 0
Totale 15.653